Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jan 8, 2010Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
Boston Scientific Corporation (NYSE: BSX) announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare...
-
Jan 5, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming J.P. Morgan Health Care Conference in San Francisco. Ray...
-
Jan 5, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its MAPS™ clinical trial, which is studying the...
-
Jan 4, 2010Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study
Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study...
-
Dec 23, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement with the U.S. Department of Justice regarding...
-
Dec 16, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Nelda Connors as a Director. Ms....
-
Dec 14, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the completion of a public offering of $2 billion aggregate principal amount of its...
-
Dec 10, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior...
-
Nov 23, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Ray Elliott,...
-
Nov 20, 2009Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug...